GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Helius Medical Technologies Inc (NAS:HSDT) » Definitions » Current Ratio

Helius Medical Technologies (Helius Medical Technologies) Current Ratio : 3.96 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Helius Medical Technologies Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Helius Medical Technologies's current ratio for the quarter that ended in Dec. 2023 was 3.96.

Helius Medical Technologies has a current ratio of 3.96. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Helius Medical Technologies's Current Ratio or its related term are showing as below:

HSDT' s Current Ratio Range Over the Past 10 Years
Min: 0.46   Med: 1.7   Max: 8.4
Current: 3.96

During the past 10 years, Helius Medical Technologies's highest Current Ratio was 8.40. The lowest was 0.46. And the median was 1.70.

HSDT's Current Ratio is ranked better than
65.44% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 2.7 vs HSDT: 3.96

Helius Medical Technologies Current Ratio Historical Data

The historical data trend for Helius Medical Technologies's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helius Medical Technologies Current Ratio Chart

Helius Medical Technologies Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.90 1.93 4.75 8.40 3.96

Helius Medical Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.40 7.38 6.74 5.98 3.96

Competitive Comparison of Helius Medical Technologies's Current Ratio

For the Medical Devices subindustry, Helius Medical Technologies's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helius Medical Technologies's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's Current Ratio distribution charts can be found below:

* The bar in red indicates where Helius Medical Technologies's Current Ratio falls into.



Helius Medical Technologies Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Helius Medical Technologies's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=7.438/1.879
=3.96

Helius Medical Technologies's Current Ratio for the quarter that ended in Dec. 2023 is calculated as

Current Ratio (Q: Dec. 2023 )=Total Current Assets (Q: Dec. 2023 )/Total Current Liabilities (Q: Dec. 2023 )
=7.438/1.879
=3.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Helius Medical Technologies  (NAS:HSDT) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Helius Medical Technologies Current Ratio Related Terms

Thank you for viewing the detailed overview of Helius Medical Technologies's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Helius Medical Technologies (Helius Medical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
642 Newtown Yardley Road, Suite 100, Newtown, PA, USA, 18940
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Executives
Dane Andreeff director, 10 percent owner, officer: President and CEO C/O ANDREEFF EQUITY ADVISORS L.L.C., 140 E. ST. LUCIA LANE, SANTA ROSA BEACH FL 32459
Jeffrey S Mathiesen director, officer: CFO and Treasurer 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167
Favit-van Pelt Antonella R. officer: Chief Medical Officer C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, NEWTOWN PA 18940
Paul Buckman director 12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402
Sherrie L Perkins director 5033 TANGLE LANE, HOUSTON TX 77056
Jennifer Laux officer: Chief Commercial Officer 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN PA 18940
Thomas E Griffin director C/O ENTELLUS MEDICAL, INC., 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Blane Walter director 500 OLDE WORTHINGTON ROAD, WESTERVILLE OH 43082
Edward M Straw director C/O ESTEE LAUDER COMPANIES, 767 FIFTH AVENUE, NEW YORK NY 10153
Joyce N Laviscount officer: See Remarks 100 ENDO BOULEVARD, CHADDS FORD PA 19317
Huaizheng Peng director HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Philippe Deschamps director, 10 percent owner, officer: President & CEO 105 BRADFORD RD, SUITE 420, WEXFORD PA 15090
Mitch E Tyler director HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Jonathan Sackier 10 percent owner, officer: Chief Medical Officer HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
A&b (hk) Co Ltd 10 percent owner 8/F BLDG A TONGFANG INFORMATION HARBOR, NO 11 LANGSHAN ROAD NANSHAN DISTRICT, SHENZHEN F4 518057

Helius Medical Technologies (Helius Medical Technologies) Headlines

From GuruFocus